Ana Royuela
Instituto de Salud Carlos III · 306 works · 7,018 citations · h-index 40
Top works
- Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
- Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain
- Interventions for Old World cutaneous leishmaniasis
- Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
- Steroid avoidance or withdrawal for kidney transplant recipients
- Minimal Clinically Important Change for Pain Intensity and Disability in Patients With Nonspecific Low Back Pain
- Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
- The Efficacy of a Short Education Program and a Short Physiotherapy Program for Treating Low Back Pain in Primary Care
- Lumbar Spine: Agreement in the Interpretation of 1.5-T MR Images by Using the Nordic Modic Consensus Group Classification Form
- Prevalence and Factors Associated With Low Back Pain and Pelvic Girdle Pain During Pregnancy
- Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis
- Minimal Clinically Important Difference in Quality of Life for Patients With Low Back Pain
- A Systematic Review on Steroid Withdrawal Between 3 and 6 Months After Kidney Transplantation
- To burn-out or not to burn-out: a cross-sectional study in healthcare professionals in Spain during COVID-19 pandemic
- Steroid avoidance or withdrawal for kidney transplant recipients
- Vertebral Endplate Changes Are Not Associated with Chronic Low Back Pain among Southern European Subjects: A Case Control Study
- Psychometric characteristics of the Spanish version of instruments to measure neck pain disability
- Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review
- OA20.01 Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study
- OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy